Key result
This review outlines the incidence, pathophysiology, diagnosis, and treatment of supraventricular arrhythmias, including electrocardiogram findings and pharmacologic agents.
This paper provides a basic review of the incidence, pathophysiology, diagnosis, and treatment of supraventricular arrhythmias for healthcare providers.
Supports clinician education on supraventricular arrhythmia management; leaves open the need for prospective validation of emerging therapies.
Supraventricular arrhythmias are the most wide-spread group of arrhythmias and affect all age groups. Atrial fibrillation is the most common arrhythmic disorder and is even more prevalent among the elderly. Due to their prevalence, it is imperative for the clinician to be informed about these arrhythmias and treatment considerations. This paper presents a basic review of the incidence, pathophysiology, diagnosis, and treatment of supraventricular arrhythmias, along with gender differences, and discusses important implications for the health care provider. A summary of common electrocardiogram findings in supraventricular arrhythmias is presented along with a brief overview of pharmacologic agents.
No takes yet. Share an insight, caveat, or question.
Carol Chen‐Scarabelli (2005) conducted a review in Supraventricular arrhythmias. This review outlines the incidence, pathophysiology, diagnosis, and treatment of supraventricular arrhythmias, including electrocardiogram findings and pharmacologic agents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: